122 related articles for article (PubMed ID: 7551223)
1. Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccines.
Lidgate DM; Byars NE
Pharm Biotechnol; 1995; 6():313-24. PubMed ID: 7551223
[No Abstract] [Full Text] [Related]
2. [Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant].
Chen ZY; Chen LF; Gong XQ
Yao Xue Xue Bao; 1982 Jun; 17(6):425-30. PubMed ID: 7148465
[No Abstract] [Full Text] [Related]
3. Syntex adjuvant formulation.
Allison AC; Byars NE
Res Immunol; 1992 Jun; 143(5):519-25. PubMed ID: 1439132
[No Abstract] [Full Text] [Related]
4. Synthesis of biologically active biotinylated muramyl dipeptides.
Grimes CL; Podolsky DK; O'Shea EK
Bioorg Med Chem Lett; 2010 Oct; 20(20):6061-3. PubMed ID: 20822907
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of immunologically active muramyl dipeptide derivatives containing a quinonyl moiety via aminoacyl intermediates.
Fukuda T; Kobayashi S; Yukimasa H; Imada I; Fujino M; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2215-21. PubMed ID: 7318034
[No Abstract] [Full Text] [Related]
6. Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle.
Lidgate DM; Fu RC; Byars NE; Foster LC; Fleitman JS
Pharm Res; 1989 Sep; 6(9):748-52. PubMed ID: 2813271
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
[No Abstract] [Full Text] [Related]
8. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation.
Solange A
Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities.
Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I
Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036
[TBL] [Abstract][Full Text] [Related]
10. Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides.
Lefrancier P; Derrien M; Jamet X; Choay J; Lederer E; Audibert F; Parant M; Parant F; Chedid L
J Med Chem; 1982 Jan; 25(1):87-90. PubMed ID: 7086827
[No Abstract] [Full Text] [Related]
11. New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV).
Zhao N; Ma Y; Zhang S; Fang X; Liang Z; Liu G
Bioorg Med Chem Lett; 2011 Jul; 21(14):4292-5. PubMed ID: 21683593
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
Ott G; Barchfeld GL; Van Nest G
Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
[TBL] [Abstract][Full Text] [Related]
13. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant formulations and their mode of action.
Allison AC; Byars NE
Semin Immunol; 1990 Sep; 2(5):369-74. PubMed ID: 1966859
[TBL] [Abstract][Full Text] [Related]
15. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). II. Use of compounds of the muramyl dipeptide (MDP) family as adjuvants.
Nash HA; Chang CC; Tsong YY
J Reprod Immunol; 1985 Feb; 7(2):151-62. PubMed ID: 3981488
[TBL] [Abstract][Full Text] [Related]
16. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido-2,3,di-deoxy-6-thio-D-glucopyranose-3-yl)-D-lac toy l]-L- alanyl-D-isoglutamine derivatives.
Hasegawa A; Seki E; Hioki Y; Kiso M; Azuma I
Carbohydr Res; 1984 Jul; 129():271-7. PubMed ID: 6467247
[No Abstract] [Full Text] [Related]
18. Solid-phase synthesis of muramyl dipeptide (MDP) derivatives using a multipin method.
Liu G; Zhang SD; Xia SQ; Ding ZK
Bioorg Med Chem Lett; 2000 Jun; 10(12):1361-3. PubMed ID: 10890164
[TBL] [Abstract][Full Text] [Related]
19. Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants.
Turánek J; Ledvina M; Kasná A; Vacek A; Hríbalova V; Krejcí J; Miller AD
Vaccine; 2006 Apr; 24 Suppl 2():S2-90-1. PubMed ID: 16823942
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine.
Ishida H; Kitagawa M; Kiso M; Hasegawa A; Azuma I
Carbohydr Res; 1990 Dec; 208():267-72. PubMed ID: 2085813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
